北美色素沉着症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型（药妆、光疗或激光疗法、微晶换肤术、化学换肤术、冷冻疗法等）、病症（黄褐斑、日光性雀斑、炎症后色素沉着等）和最终用户（医院、皮肤病中心等）
黄褐斑患病率上升推动北美色素沉着症治疗市场发展
黄褐斑是最主要的色素沉着症之一，其特征是面部出现对称的浅色至深色泥褐色斑点，尤其是下巴、上唇、鼻子、前额和脸颊。它在女性和肤色较黑的人群中很常见。颧骨、下颌和面部中央的临床特征在黄褐斑中很常见。日晒、荷尔蒙变化、怀孕、遗传因素、化妆品和药物都与黄褐斑的形成有关。各种研究估计，黄褐斑在普通人群中的总体患病率为 1% 至 50%。55–64% 的黄褐斑病例报告有相同疾病的家族史。此外，据报道，东亚和西班牙裔人群以及 Fitzpatrick 皮肤光型较高（IV 至 VI）的患者患病率更高；居住在受到强烈紫外线辐射的地方的人患病率也更高。
怀孕是黄褐斑的另一个常见原因。这种疾病也会影响服用口服避孕药和激素的女性。雌激素、孕酮和促黑素细胞激素水平通常在妊娠晚期升高，这可能是一个因素。根据美国国家生物技术信息中心 (NCBI) 2023 年 8 月的数据，黄褐斑在育龄妇女中更为常见，在青春期前很少发生；15–50% 的孕妇会出现这种情况，其患病率为 1.5% 至 33%，具体取决于不同地区的人口。因此，黄褐斑患病率的上升引发了对色素沉着治疗的需求。
北美色素沉着障碍治疗市场概览
北美的色素沉着障碍治疗市场分为美国、加拿大和墨西哥。 2023 年，美国占据了北美最大的色素沉着症治疗市场份额。根据《2024 年有色皮肤更新》（一场皮肤病学会议），随着美国西班牙裔、亚裔和非洲裔的国际移民推动民族和种族多样性的增长，美国的人口结构正在发生变化，这也可能会导致 2050 年左右少数族裔人口向菲茨帕特里克 III、IV、V 和 VI 型皮肤人群转变。具体来说，西班牙裔人口预计将成为美国增长最快的人口群体之一，预计将从 2014 年的 5500 万增长到 2060 年的 1.19 亿。深色皮肤更容易患色素沉着症。
过去 10 年，美国的美容手术数量显着增加。根据国际整形外科医师协会 (ISAPS) 的数据，2021 年全球非手术美容手术数量与 2020 年相比增长了 19.9%。强脉冲光 (IPL) 治疗是排名前五的微创美容手术之一，2020 年美国进行了约 827,000 例 IPL 手术。因此，非侵入性手术的技术进步可能会进一步使美国的色素沉着症治疗市场受益。2023 年 3 月，美国食品药品监督管理局 (FDA) 批准 Candela Corporation 的 PicoWay 激光用于治疗咖啡牛奶斑、黄褐斑、雀斑和太田痣。此前，该激光系统已获准用于治疗良性色素病变、痤疮疤痕、皱纹和纹身去除等。
因此，种族和民族多样性的不断增长，以及药妆、化学换肤、冷冻疗法、光疗或激光疗法等非侵入性医学美容程序的发展等因素促进了美国色素沉着症治疗市场的增长。
北美色素沉着症治疗市场收入及预测至 2030 年（百万美元）
北美色素沉着症治疗市场细分
北美色素沉着症治疗市场分为治疗类型、病症、最终用户和国家。
根据治疗类型，北美色素沉着症治疗市场分为药妆、光疗或激光疗法、微晶换肤、化学换肤、冷冻疗法等。 2022 年，药妆品市场占有最大份额。
根据病情，北美色素沉着症治疗市场细分为黄褐斑、日光性雀斑、炎症后色素沉着等。2022 年，黄褐斑细分市场占有最大份额。
根据最终用户，北美色素沉着症治疗市场细分为医院、皮肤病中心等。2022 年，医院细分市场占有最大份额。
按国家/地区划分，北美色素沉着症治疗市场细分为美国、加拿大和墨西哥。 2022 年，美国占据了北美色素沉着症治疗市场的主导份额。
AbbVie Inc、Bayer AG、Galderma SA、L\'OREAL SA、Lutronic Co Ltd、Obagi Cosmeceuticals LLC 和 Vivier Pharma Inc 是北美色素沉着症治疗市场的一些领先公司。
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Rise in Prevalence of Melasma
4.1.2 Increasing Number of Hyperpigmentation Disorder Awareness Programs
4.2 Market Restraints
4.2.1 High Cost of Treatments
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Market Players
4.4 Future Trends
4.4.1 Use of Ablative Lasers
4.4.2 Novel Products Based on PATH-3 Technology
4.5 Impact of Drivers and Restraints:
5. Hyperpigmentation Disorder Treatment Market - North America Analysis
5.1 North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2020-2030
6. North America Hyperpigmentation Disorder Treatment Market Analysis - by Treatment Type
6.1 Cosmeceutical
6.1.1 Overview
6.1.2 Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.2 Light or Laser Therapy
6.2.1 Overview
6.2.2 Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Microdermabrasion
6.3.1 Overview
6.3.2 Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Chemical Peels
6.4.1 Overview
6.4.2 Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Cryotherapy
6.5.1 Overview
6.5.2 Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.6 Others
6.6.1 Overview
6.6.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7. North America Hyperpigmentation Disorder Treatment Market Analysis - by Condition
7.1 Melasma
7.1.1 Overview
7.1.2 Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.2 Solar Lentigines
7.2.1 Overview
7.2.2 Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Post-inflammatory Hyperpigmentation
7.3.1 Overview
7.3.2 Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8. North America Hyperpigmentation Disorder Treatment Market Analysis - by End User
8.1 Hospitals
8.1.1 Overview
8.1.2 Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.2 Dermatology Centers
8.2.1 Overview
8.2.2 Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9. North America Hyperpigmentation Disorder Treatment Market - Country Analysis
9.1 North America Hyperpigmentation Disorder Treatment Market
9.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
9.1.1.1 North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast Analysis - by Country
9.1.1.2 US
9.1.1.3 US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.3.1 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.3.2 US: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.3.3 US: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.4 Canada
9.1.1.5 Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.5.1 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.5.2 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.5.3 Canada: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
9.1.1.6 Mexico
9.1.1.7 Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.1.1.7.1 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Treatment Type
9.1.1.7.2 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by Condition
9.1.1.7.3 Mexico: Hyperpigmentation Disorder Treatment Market Breakdown, by End User
10. Hyperpigmentation Disorder Treatment Market - Industry Landscape
10.1 Overview
10.2 Growth Strategies in Hyperpigmentation Disorder Treatment Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 AbbVie Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Galderma SA
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Obagi Cosmeceuticals LLC
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Bayer AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Lutronic Co Ltd
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 L'OREAL S.A.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Pierre Fabre SA
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Vivier Pharma Inc
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. North America Hyperpigmentation Disorder Treatment Market Segmentation
Table 2. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 3. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 4. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 5. North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Country
Table 6. Number of Laser-Based Nonsurgical Procedures Performed, 2020
Table 7. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 8. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 9. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 10. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 11. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 12. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 13. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Treatment Type
Table 14. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by Condition
Table 15. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million) - by End User
Table 16. Recent Organic Growth Strategies in Hyperpigmentation Disorder Treatment Market
Table 17. Recent Inorganic Growth Strategies in the Hyperpigmentation Disorder Treatment Market
Table 18. Glossary of Terms, Hyperpigmentation Disorder Treatment Market
List of Figures
Figure 1. North America Hyperpigmentation Disorder Treatment Market Segmentation, by Country
Figure 2. North America Hyperpigmentation Disorder Treatment Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Hyperpigmentation Disorder Treatment Market Revenue (US$ Million), 2022-2030
Figure 5. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Treatment Type (2022 and 2030)
Figure 6. Cosmeceutical: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Light or Laser Therapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Microdermabrasion: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Chemical Peels: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Cryotherapy: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. North America Hyperpigmentation Disorder Treatment Market Share (%) - by Condition (2022 and 2030)
Figure 13. Melasma: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Solar Lentigines: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Post-inflammatory Hyperpigmentation: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Hyperpigmentation Disorder Treatment Market Share (%) - by End User (2022 and 2030)
Figure 18. Hospitals: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Dermatology Centers: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Others: North America Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Hyperpigmentation Disorder Treatment Market, By Key Country - Revenue (2022) (US$ Million)
Figure 22. North America Hyperpigmentation Disorder Treatment Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 23. US: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Canada: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Mexico: Hyperpigmentation Disorder Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. Growth Strategies in Hyperpigmentation Disorder Treatment Market
- AbbVie Inc
- Bayer AG
- Galderma SA
- L'OREAL S.A.
- Lutronic Co Ltd
- Obagi Cosmeceuticals LLC
- Vivier Pharma Inc
- Pierre Fabre Group
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America hyperpigmentation disorder treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America hyperpigmentation disorder treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the North America hyperpigmentation disorder treatment market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.